Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. DATA SOURCES: The first two patients in the United States treated with the novel Sera...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Crit Care Explor
Prif Awduron: Olson, Stephen W., Oliver, James D., Collen, Jacob, Bunin, Jessica, Gleeson, Todd D., Foster, Brian E., Simmons, Mark P., Chen, Hua W., Ficke, Jennifer B., Brown, Tara E., Nau, Mark T., Cebula, Brennan R., Kielstein, Jan, Chung, Kevin K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2020
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396271/
https://ncbi.nlm.nih.gov/pubmed/32766569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000180
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg